Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

ClinicalTrials.gov ID: NCT06662383

Public ClinicalTrials.gov record NCT06662383. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of retatrutide compared to tirzepatide in adults who have obesity. The study will last about 89 weeks.

Study identification

NCT ID
NCT06662383
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
800 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1, 2024 (Actual)
Primary completion
Nov 2026 (Estimated)
Completion
Dec 2026 (Estimated)
Last update posted
Jul 20, 2026

2024 – 2026

United States locations

U.S. sites
40
U.S. states
22
U.S. cities
38
Facility City State ZIP Site status
Medical Advancement Centers of Arizona Tempe Arizona 85283 —
Mary & Dick Allen Diabetes Center Newport Beach California 92663 —
Artemis Institute for Clinical Research San Diego California 92103 —
Encompass Clinical Research Spring Valley California 91978 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Lynn Institute of Denver Aurora Colorado 80012 —
Bridgeport Hospital Bridgeport Connecticut 06610 —
Yale University School of Medicine New Haven Connecticut 06519 —
Encore Medical Research Hollywood Florida 33024 —
Suncoast Research Group Miami Florida 33135 —
Onhealth Research Center Miami Florida 33186 —
Precision Clinical Research Sunrise Florida 33351 —
Einstein Clinical Research Vero Beach Florida 32960 —
ClinCept Clinical Research - MH Columbus Georgia 31904 —
Northeast Georgia Medical Center Gainesville Georgia 30501 —
Pivotal Research Solutions Stonecrest Georgia 30038 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Northwestern University Chicago Illinois 60611 —
Integrated Clinical Trial Services, Inc. West Des Moines Iowa 50265 —
Pennington Biomedical Research Center Baton Rouge Louisiana 70808 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
Great Lakes Research Institute Southfield Michigan 48075 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Las Vegas Endocrinology Henderson Nevada 89074 —
Albany Medical College, Division of Community Endocrinology Albany New York 12203 —
New York Gastroenterology Associates New York New York 10075 —
Westchester Medical Center Valhalla New York 10595 —
PharmQuest Life Sciences, LLC Greensboro North Carolina 27408 —
Monroe Biomedical Research Monroe North Carolina 28112 —
Accellacare - Wilmington Wilmington North Carolina 28401 —
Lillestol Research Fargo North Dakota 58104 —
PriMED Clinical Research Dayton Ohio 45429 —
Tribe Clinical Research, LLC Greenville South Carolina 29607 —
WR-Clinsearch, LLC Chattanooga Tennessee 37421 —
Headlands Horizons LLC Brownsville Texas 78526 —
Next Level Urgent Care Houston Texas 77057 —
Houston Research Institute Houston Texas 77079 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Chrysalis Clinical Research St. George Utah 84790 —
Charlottesville Medical Research Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06662383, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06662383 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →